[The behavior of genetically purified influenza A2 strains in cell cultures].
D000327:Adsorption; D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D002417:Cattle; D002460:Cell Line; D002642:Chick Embryo; D002645:Chickens; D002999:Clone Cells; D003228:Conjunctiva; D003470:Culture Media; D046508:Culture Techniques; D004352:Drug Resistance, Microbial; D004912:Erythrocytes / Q000276:immunology; D005347:Fibroblasts; D005827:Genetics, Microbial; D006168:Guinea Pigs; D000882:Haplorhini; D006382:Hemadsorption; D006386:Hemagglutination Tests; D006387:Hemagglutination, Viral; D006736:Horses; D006801:Humans; D007106:Immune Sera; D007668:Kidney; D008168:Lung; D008297:Male; D009439:Neuraminidase / Q000494:pharmacology; D009975:Orthomyxoviridae / Q000187:drug effects / Q000254:growth & development* / Q000472:pathogenicity; D013737:Testis; D014733:Vibrio; D014779:Virus Replication
D000998:Antiviral Agents; D003470:Culture Media; D007106:Immune Sera; D000547:Amantadine; D009439:Neuraminidase
Verhalten von genetisch weitgehend reinen Influenza A2 Stämmen in Zellkulturen.